Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Kelsen

Showing results (41-50 of 77) with videos related to

Pageof 8
Sort By:
Seminars in Oncology|October 1, 1994
A phase II trial of paclitaxel (Taxol) in advanced esophageal cancer: preliminary reportD Kelsen, J Ajani, D Ilson, et al.
Cancer Treatment Reports|June 1, 1985
Phase II trial of high-dose cisplatin in patients with malignant mesotheliomaD M Mintzer, D Kelsen, D Frimmer, et al.
Cancer|October 1, 1992
A phase II trial of biochemical modulation using N-phosphonacetyl-L-aspartate, high-dose methotrexate, high-dose 5-fluorouracil, and leucovorin in patients with adenocarcinoma of unknown primary siteD Kelsen, D S Martin, J Colofiore, et al.
Cancer Treatment Reports|November 1, 1984
Phase II study of 4-demethoxydaunorubicin in patients with adenocarcinoma of the upper gastrointestinal tractA Einzig, D Kelsen, E Cheng, et al.
Cancer Treatment Reports|June 1, 1982
Phase II study of methyl-GAG in the treatment of esophageal carcinomaD Kelsen, R Chapman, M Bains, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1982
Phase II trial of VP16-213 in non-small cell lung cancer (NSCLC)R Chapman, L Itri, R Gralla, et al.
Journal of the National Cancer Institute|November 15, 1989
Advanced pancreatic cancer: a phase I-II trial of cisplatin, high-dose cytarabine, and caffeineJ B Dougherty, D Kelsen, N Kemeny, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1984
Phase-II trial of 1,2-diaminocyclohexane (4-carboxyphthalato) platinum (II) (DACCP) in non-small cell lung cancerH I Scher, D Kelsen, L Kalman, et al.
Cancer|July 1, 1993
Octreotide as an antineoplastic agent in the treatment of functional and nonfunctional neuroendocrine tumorsL Saltz, B Trochanowski, M Buckley, et al.
American Journal of Clinical Oncology|August 1, 1988
A phase II trial of streptozotocin and adriamycin in advanced APUD tumorsJ Frame, D Kelsen, N Kemeny, et al.
Pageof 8

Showing results (41-50 of 77) with videos related to

Sort By:
Pageof 8
Seminars in Oncology|October 1, 1994
A phase II trial of paclitaxel (Taxol) in advanced esophageal cancer: preliminary reportD Kelsen, J Ajani, D Ilson, et al.
Cancer Treatment Reports|June 1, 1985
Phase II trial of high-dose cisplatin in patients with malignant mesotheliomaD M Mintzer, D Kelsen, D Frimmer, et al.
Cancer|October 1, 1992
A phase II trial of biochemical modulation using N-phosphonacetyl-L-aspartate, high-dose methotrexate, high-dose 5-fluorouracil, and leucovorin in patients with adenocarcinoma of unknown primary siteD Kelsen, D S Martin, J Colofiore, et al.
Cancer Treatment Reports|November 1, 1984
Phase II study of 4-demethoxydaunorubicin in patients with adenocarcinoma of the upper gastrointestinal tractA Einzig, D Kelsen, E Cheng, et al.
Cancer Treatment Reports|June 1, 1982
Phase II study of methyl-GAG in the treatment of esophageal carcinomaD Kelsen, R Chapman, M Bains, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1982
Phase II trial of VP16-213 in non-small cell lung cancer (NSCLC)R Chapman, L Itri, R Gralla, et al.
Journal of the National Cancer Institute|November 15, 1989
Advanced pancreatic cancer: a phase I-II trial of cisplatin, high-dose cytarabine, and caffeineJ B Dougherty, D Kelsen, N Kemeny, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1984
Phase-II trial of 1,2-diaminocyclohexane (4-carboxyphthalato) platinum (II) (DACCP) in non-small cell lung cancerH I Scher, D Kelsen, L Kalman, et al.
Cancer|July 1, 1993
Octreotide as an antineoplastic agent in the treatment of functional and nonfunctional neuroendocrine tumorsL Saltz, B Trochanowski, M Buckley, et al.
American Journal of Clinical Oncology|August 1, 1988
A phase II trial of streptozotocin and adriamycin in advanced APUD tumorsJ Frame, D Kelsen, N Kemeny, et al.
Pageof 8